secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2022-10-31T23:59:59+00:00
Accession:  0001193125-22-273110
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD raises $7M from Rubric Capital; extends debt maturity to Nov 30
------------------------------------------------------------------------------

- Issued 7,000 shares of Series A Preferred Stock to Rubric Capital Management for $7M gross proceeds.
- Net proceeds to be used for working capital and general corporate purposes.
- Financing agreement maturity extended to Nov 30, 2022; lenders received warrants for 125k shares at $0.01.
- Warrants have a 10-year term and are exercisable via cashless exercise.
- Board and management continue to assess strategic alternatives to strengthen long-term financial position.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000119312522273110/0001193125-22-273110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000119312522273110/d394277d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-273110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer